TrialBritish journal of clinical pharmacology2013

Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies.

Montserrat Abadias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.